def14a
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
|
|
|
þ
|
|
Filed by the Registrant
|
o
|
|
Filed by a party other than the Registrant |
Check the appropriate box: |
o
|
|
Preliminary Proxy Statement |
o
|
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ
|
|
Definitive Proxy Statement |
o
|
|
Definitive Additional Materials |
o
|
|
Soliciting Material Pursuant to § 240.14a-12 |
Criticare Systems, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
|
Payment of filing fee (Check the appropriate box): |
þ
|
|
No fee required. |
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) Title of each class of securities to which transaction applies:
Not Applicable
(2) Aggregate number of securities to which transaction applies:
Not Applicable
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange
Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it
was determined):
Not Applicable
(4) Proposed maximum aggregate value of transaction:
Not Applicable
(5) Total fee paid:
Not Applicable
o Fee paid previously with preliminary materials.
o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of
its filing.
(1) Amount previously paid:
Not Applicable
(2) Form, Schedule or Registration Statement No.:
Not Applicable
(3) Filing Party:
Not Applicable
(4) Date Filed:
Not Applicable
CRITICARE
SYSTEMS, INC.
20925 Crossroads Circle,
Suite 100
Waukesha, Wisconsin 53186
Notice of Annual Meeting of Stockholders
The Annual Meeting of Stockholders of Criticare Systems, Inc.
will be held at the Companys headquarters, 20925
Crossroads Circle, Suite 100, Waukesha, Wisconsin 53186, on
November 27, 2007 at 4:00 p.m., local time, for the
following purposes:
1. To elect five directors each to serve until the 2008
Annual Meeting of Stockholders.
2. To ratify the appointment of BDO Seidman, LLP,
independent registered public accounting firm, as auditors of
the Company for its fiscal year ending June 30, 2008.
3. To transact any other business as may properly come
before the meeting and any adjournment or adjournments thereof.
The transfer books of the Company will not be closed for the
Annual Meeting. Stockholders of record at the close of business
on October 10, 2007 are entitled to receive notice of, and
to vote at, the Annual Meeting.
All stockholders are cordially invited to attend the meeting in
person, if possible. Stockholders who are unable to be present
in person are requested to complete, sign and date the enclosed
proxy and return it promptly in the enclosed envelope. Your
attendance at the meeting, whether in person or by proxy, is
important to ensure a quorum. If you later find that you may be
present at the meeting or for any other reason desire to revoke
your proxy, you may do so at any time before it is voted.
Stockholders holding shares in brokerage accounts (street
name holders) who wish to vote at the meeting will need to
obtain a proxy form from the institution that holds their shares.
By Order of the Board of Directors
Joel D. Knudson, Secretary
Waukesha, Wisconsin
October 30, 2007
TABLE OF
CONTENTS
|
|
|
|
|
Section
|
|
Page No.
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
4
|
|
|
|
|
4
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
6
|
|
|
|
|
6
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
14
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
17
|
|
|
|
|
19
|
|
|
|
|
19
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
21
|
|
CRITICARE
SYSTEMS, INC.
20925 Crossroads Circle,
Suite 100
Waukesha, Wisconsin 53186
PROXY
STATEMENT FOR 2007 ANNUAL MEETING OF STOCKHOLDERS
This Proxy Statement is furnished in connection with the
solicitation of proxies by the Board of Directors of Criticare
Systems, Inc. (the Company), to be voted at the
Annual Meeting of Stockholders to be held at the Companys
headquarters, 20925 Crossroads Circle, Suite 100, Waukesha,
Wisconsin 53186, at 4:00 p.m., local time, on Tuesday,
November 27, 2007, and at any adjournments thereof, for the
purposes set forth in the accompanying Notice of Meeting. The
mailing of this Proxy Statement and accompanying form of proxy
is being made on or about October 30, 2007.
The Board of Directors knows of no business, which will be
presented to the meeting other than the matters referred to in
the accompanying Notice of Annual Meeting. However, if any other
matters are properly presented to the meeting, it is intended
that the persons named in the proxy will vote on such matters in
accordance with their judgment. If the enclosed form of proxy is
executed and returned, it nevertheless may be revoked at any
time before it has been voted by a later dated proxy or a vote
in person at the Annual Meeting. Shares represented by properly
executed proxies received on behalf of the Company will be voted
at the Annual Meeting (unless revoked prior to their vote) in
the manner specified therein. If no instructions are specified
in a signed proxy returned to the Company, the shares
represented thereby will be voted (1) in FAVOR of
the election of the nominees listed in the enclosed proxy as
directors of the Company and (2) in FAVOR of the
ratification of BDO Seidman, LLP as the Companys
independent registered public accounting firm for the 2008
fiscal year.
Only holders of the Companys common stock, par value $0.04
per share (the Common Stock), whose names appear of
record on the books of the Company at the close of business on
October 10, 2007 (the Record Date) are entitled
to vote at the Annual Meeting. On that date, the only
outstanding shares of capital stock of the Company were
12,319,831 shares of Common Stock. Each share of Common
Stock is entitled to one vote on each matter to be presented at
the meeting. The election of the directors requires the
affirmative vote of the holders of a plurality of the shares
represented, in person or by proxy, at the meeting and the
ratification of the Companys independent registered public
accounting firm requires the affirmative vote of the holders of
a majority of the shares represented, in person or by proxy, at
the meeting. Abstentions and broker non-votes (i.e.,
shares held by brokers in street name, voting on certain matters
due to discretionary authority or instructions from the
beneficial owners but not voting on other matters due to lack of
authority to vote on such matters without instructions from the
beneficial owner) will count toward the quorum requirement and
will not count toward the determination of whether the directors
are elected or the appointment of the independent registered
public accounting firm is ratified.
Pursuant to the authority contained in our By-Laws, our Board of
Directors has established the number of our directors at five.
Our By-Laws have been amended to provide that, effective as of
the 2007 Annual Meeting of Stockholders, our Board of Directors
will be declassified, with each director elected for one-year
terms. Accordingly, our Board of Directors has nominated for
re-election five of the current directors, each to serve a term
of one year until the 2008 Annual Meeting of Stockholders.
Proxies cannot be voted for more than five candidates for
director.
Sam B. Humphries, a former director of the Company, passed away
on August 7, 2007.
Dr. Higgins D. Bailey will retire from the Board and
as Chairman of the Board as of the 2007 Annual Meeting of
Stockholders. Jeffrey T. Barnes, Vice Chairman of the
Board, will succeed to the functions of Chairman of the Board
until a new Chairman of the Board is elected.
The directorships of Robert E. Munzenrider and
William M. Moore are connected with the termination of the
consent solicitation commenced by BlueLine Partners L.L.C.
pursuant to the terms of an Agreement dated as of April 2,
2007 among the Company, BlueLine Catalyst Fund VII, L.P.,
BlueLine Partners, L.L.C. (California), BlueLine Capital
Partners, L.P. and BlueLine Partners L.L.C. (Delaware).
As indicated below, the persons nominated by our Board of
Directors are incumbent directors. We anticipate that the
nominees will be candidates when the election is held. However,
if for any reason either of the nominees is not a candidate at
that time, proxies will be voted for any substitute nominee
designated by the incumbent directors (except where a proxy
withholds authority with respect to the election of a director).
The Board of Directors recommends that stockholders vote in
FAVOR of the election all incumbent directors of the Company.
|
|
|
|
|
|
|
|
|
|
|
Name, Age, Principal Occupation for
|
|
|
|
Director
|
|
|
Past Five Years and Directorships
|
|
Age
|
|
Since
|
|
Present Term Ends
|
|
Nominees For Election as Directors
|
|
|
|
|
|
|
|
|
|
|
Jeffrey T. Barnes
|
|
|
53
|
|
|
|
2000
|
|
|
2007 Annual Meeting
|
Mr. Barnes has served as our Vice Chairman of the Board since
August 2006. Mr. Barnes has been a partner of Oxford
Bioscience, a venture capital firm, since October 1999. From
February 1997 to October 1999, Mr. Barnes served as a
Principal of Robertson Stephens, an investment banking firm.
|
|
|
|
|
|
|
|
|
|
|
N.C. Joseph Lai, Ph.D.
|
|
|
65
|
|
|
|
1984
|
|
|
2007 Annual Meeting
|
Dr. Lai has served as Executive Chairman of BioForm, Inc.,
a company that produces special medical devices, since December
2002. From June 1999 to December 2002, Dr. Lai served as
President and Chief Executive Officer of BioForm, Inc.
Dr. Lai was a co-founder of the Company and served as Vice
Chairman of its Board and as an officer from the Companys
inception in October 1984 until November 1998.
|
|
|
|
|
|
|
|
|
|
|
William M. Moore
|
|
|
59
|
|
|
|
2007
|
|
|
2007 Annual Meeting
|
Mr. Moore has served as a director of BlueLine Partners, L.L.C.
since February 2004 and as a general partner of Alpine Partners,
a venture capital firm, since March 2003. Mr. Moore served
as Chief Executive Officer of Metasensors, Inc., a medical
device company, from August 1997 to March 2003. Mr. Moore
is a co-founder and director of Natus Medical Inc., a medical
device company, and a director of IRIDEX Corporation, a provider
of therapeutic based laser systems and delivery devices used to
treat eye diseases in ophthalmology and skin conditions in
dermatology.
|
|
|
|
|
|
|
|
|
|
|
Robert E. Munzenrider
|
|
|
62
|
|
|
|
2007
|
|
|
2007 Annual Meeting
|
Mr. Munzenrider was the President of Harmon AutoGlass, a
subsidiary of Apogee Enterprises, Inc., a national chain of
retail automotive services and insurance claims processor, from
2000 to 2002. From 1999 to 2000, Mr. Munzenrider served as
Vice President and Chief Financial Officer of the Glass Services
Segment of Apogee Enterprises. He also served during part of
1999 as Executive Vice President and Chief Financial Officer of
Eliance Corp., an
e-commerce
transaction processor. From 1997 to 1998, Mr. Munzenrider
served as Vice President and Chief Financial Officer of St. Jude
Medical, Inc., an international medical device manufacturing and
marketing company. Mr. Munzenrider is also a director of
Viad Corp. and ATS Medical, Inc.
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
Name, Age, Principal Occupation for
|
|
|
|
Director
|
|
|
Past Five Years and Directorships
|
|
Age
|
|
Since
|
|
Present Term Ends
|
|
Emil H. Soika
|
|
|
69
|
|
|
|
1998
|
|
|
2007 Annual Meeting
|
Mr. Soika has served as our President and Chief Executive
Officer since November 1998. From November 1995 to September
1998, Mr. Soika served as Vice President and General
Manager of Spacelabs Medical, a medical monitoring and clinical
information systems company.
|
|
|
|
|
|
|
|
|
|
|
DIRECTORS
MEETINGS AND COMMITTEES
Our Board of Directors has an Audit Committee, a Compensation
Committee and a Nominating and Corporate Governance Committee.
The Board of Directors held 11 meetings during our fiscal year
ended June 30, 2007. All of the incumbent directors
attended at least 75% of the meetings of the Board of Directors
and of the committees of the Board of Directors upon which they
served.
The members of the Audit Committee are Dr. Higgins D.
Bailey, Dr. N.C. Joseph Lai, Jeffrey T. Barnes and Robert
E. Munzenrider (Chairman). Mr. Munzenrider joined the Audit
Committee in April 2007 and Mr. Barnes joined the Audit
Committee in August 2007. The Audit Committee met five times
during the fiscal year ended June 30, 2007. The Audit
Committee is responsible for assisting the Board of Directors
with oversight of (1) the integrity of our financial
statements, (2) our compliance with legal and regulatory
requirements, (3) the independent auditors
qualifications and independence and (4) the performance of
our internal accounting function and independent auditors. The
Audit Committee has the direct authority and responsibility to
select, evaluate and, where appropriate, replace the independent
auditors, and is an audit committee for purposes of
section 3(a)(58)(A) of the Securities Exchange Act of 1934.
The Audit Committees report required by the rules of the
Securities and Exchange Commission (SEC) appears on
page 6.
The Boards Compensation Committee is comprised of
Dr. Higgins D. Bailey (Chairman), Jeffrey T. Barnes and
William M. Moore. Mr. Moore and Mr. Barnes joined the
Compensation Committee in August 2007. Mr. Humphries served
on the Compensation Committee from November 2006 to August 2007.
The Compensation Committee, in addition to such other duties as
may be specified by the Board of Directors, reviews and makes
recommendations to the Board with respect to the compensation
levels and other benefits of executive officers, administers and
oversees our stock plans and reviews and makes recommendations
to the Board with respect to the compensation of outside
directors. We have placed a current copy of the charter of the
Compensation Committee on our website located at www.csiusa.com.
The Compensation Committee met two times during the fiscal year
ended June 30, 2007.
Nominating
and Corporate Governance Committee
The Boards Nominating and Corporate Governance Committee
is comprised of Dr. Higgins D. Bailey (Chairman), Jeffrey
T. Barnes and Robert E. Munzenrider. Mr. Barnes and
Mr. Munzenrider joined the Nominating and Corporate
Governance Committee in August 2007. The Nominating and
Corporate Governance Committee is responsible for assisting the
Board of Directors by identifying individuals qualified to
become members of the Board of Directors and its committees,
recommending to the Board of Directors nominees for the annual
meeting of stockholders, developing and recommending to the
Board of Directors a set of corporate governance principles
applicable to the Company and assisting the Board of Directors
in assessing director performance and the effectiveness of the
Board of Directors. We have placed a current copy of the charter
of the Nominating and Corporate Governance Committee on our web
site located at www.csiusa.com. Due mainly to the two consent
solicitations initiated by BlueLine Partners, during fiscal
3
2007 the full Board considered all corporate governance and
nominating topics normally discussed by the Nominating and
Corporate Governance Committee. As such, no formal meetings of
the separate committee took place during the fiscal year ended
June 30, 2007.
CORPORATE
GOVERNANCE MATTERS
We are committed to establishing and maintaining high standards
of corporate governance, which are intended to serve the
long-term interests of the Company and our stockholders. Our
Board of Directors has adopted Corporate Governance Guidelines,
which can be found on our web site at www.ciusa.com.
Our Board of Directors has reviewed the independence of its
incumbent and nominee directors under the applicable standards
of the American Stock Exchange. Based on this review, the Board
of Directors determined that each of the following directors is
independent under the listing standards of the American Stock
Exchange:
|
|
|
(1) Jeffrey T. Barnes
|
|
(3) Robert E. Munzenrider
|
(2) Dr. N.C. Joseph Lai
|
|
(4) William M. Moore
|
Based upon such standards, Emil H. Soika is the only director
who is not independent because Mr. Soika is our President
and Chief Executive Officer.
We have a standing Nominating and Corporate Governance
Committee. Based on the review described under Corporate
Governance Matters Director Independence, the
Board of Directors has determined that each member of the
Nominating and Corporate Governance Committee is independent
under the applicable standards of the American Stock Exchange.
The Nominating and Corporate Governance Committee will consider
director nominees recommended by stockholders. A stockholder who
wishes to recommend a person or persons for consideration as a
nominee for election to the Board of Directors must send a
written notice by mail,
c/o Secretary,
Criticare Systems, Inc., 20925 Crossroads Circle,
Suite 100, Waukesha, Wisconsin 53186, that sets forth:
(1) the name, address (business and residence), date of
birth and principal occupation or employment (present and for
the past five years) of each person whom the stockholder
proposes to be considered as a nominee; (2) the number of
shares of Common Stock beneficially owned (as defined by
section 13(d) of the Securities Exchange Act of
1934) by each such proposed nominee; (3) any other
information regarding such proposed nominee that would be
required to be disclosed in a definitive proxy statement to
stockholders prepared in connection with an election of
directors pursuant to section 14(a) of the Securities
Exchange Act of 1934; and (4) the name and address
(business and residential) of the stockholder making the
recommendation and the number of shares of our Common Stock
beneficially owned (as defined by section 13(d) of the
Securities Exchange Act of 1934) by the stockholder making
the recommendation. We may require any proposed nominee to
furnish additional information as may be reasonably required to
determine the qualifications of such proposed nominee to serve
as a director of the Company. Stockholder recommendations will
be considered only if received no less than 120 days nor
more than 150 days before the date of the proxy statement
sent to stockholders in connection with the previous years
annual meeting of stockholders.
The Nominating and Corporate Governance Committee will consider
any nominee recommended by a stockholder in accordance with the
preceding paragraph under the same criteria as any other
potential nominee. The Nominating and Corporate Governance
Committee believes that a nominee recommended for a position on
our Board of Directors must have an appropriate mix of director
characteristics, experience, diverse perspectives and skills.
Qualifications of a prospective nominee that may be considered
by the Nominating and Corporate Governance Committee include:
|
|
|
|
|
personal integrity and high ethical character;
|
4
|
|
|
|
|
professional excellence;
|
|
|
|
accountability and responsiveness;
|
|
|
|
absence of conflicts of interest;
|
|
|
|
fresh intellectual perspectives and ideas; and
|
|
|
|
relevant expertise and experience and the ability to offer
advice and guidance to management based on that expertise and
experience.
|
The directorships of Robert E. Munzenrider and William M. Moore
are connected with the termination of the consent solicitation
commenced by BlueLine Partners L.L.C. pursuant to the terms of
an Agreement dated as of April 2, 2007 among the Company,
BlueLine Catalyst Fund VII, L.P., BlueLine Partners, L.L.C.
(California), BlueLine Capital Partners, L.P. and BlueLine
Partners L.L.C. (Delaware).
Communications
between Stockholders and the Board of Directors
We have placed on our web site located at www.csiusa.com a
description of the procedures for stockholders to communicate
with the Board of Directors, a description of our policy for our
directors and nominee directors to attend the Annual Meeting and
the number of directors who attended last years annual
meeting of stockholders.
We have adopted a Code of Business Ethics that applies to all of
our employees, including our principal executive officer,
principal financial officer and principal accounting officer. A
copy of the Code of Business Ethics is available on our
corporate web site, which is located at www.csiusa.com. We also
intend to disclose any amendments to, or waivers from, the Code
of Business Ethics on our corporate web site.
Review
and Approval of Related Person Transactions
The charter for our Audit Committee provides that one of the
responsibilities of our Audit Committee is to review and approve
related party transactions for potential conflicts of interest.
Our Board of Directors will consider adopting a formal written
set of policies and procedures for the review, approval or
ratification of related person transactions during fiscal 2008.
5
Report
of the Audit Committee
Our Audit Committee is comprised of four members of our Board of
Directors. Based upon the review described above under
Corporate Governance Matters Director
Independence, the Board of Directors has determined that
each member of the Audit Committee is independent as defined in
the listing standards of the American Stock Exchange and the
rules of the Securities and Exchange Commission. The duties and
responsibilities of our Audit Committee are set forth in the
Audit Committee Charter. The full text of the Audit Committee
Charter is on our web site located at www.csiusa.com.
Our Audit Committee has:
|
|
|
|
|
reviewed and discussed our audited financial statements for the
fiscal year ended June 30, 2007 with our management and
with our independent auditors;
|
|
|
|
discussed with our independent auditors the matters required to
be discussed by Statement on Auditing Standards No. 61,
Communications with Audit Committees, as
revised; and
|
|
|
|
received and discussed the written disclosures and the letter
from our independent auditors required by Independence Standards
Board Statement No. 1 (Independence discussions with Audit
Committees).
|
Based on such review and discussions with management and the
independent auditors, the Audit Committee recommended to our
Board of Directors that the audited financial statements be
included in our Annual Report on
Form 10-K
for the fiscal year ended June 30, 2007, for filing with
the Securities and Exchange Commission.
AUDIT COMMITTEE:
Robert E. Munzenrider (Chairman)
Dr. Higgins D. Bailey
Dr. N.C. Joseph Lai
Jeffrey T. Barnes
Fees
of Independent Registered Public Accounting Firm
The following table summarizes the fees we were billed for audit
and non-audit services rendered by our independent auditors
during fiscal 2007 and 2006:
|
|
|
|
|
|
|
|
|
Service Type
|
|
Fiscal 2007
|
|
|
Fiscal 2006
|
|
|
Audit Fees(1)
|
|
$
|
158,500
|
|
|
$
|
170,060
|
|
Audit-related Fees
|
|
|
|
|
|
|
|
|
Tax Fees(2)
|
|
|
17,500
|
|
|
|
19,350
|
|
All Other Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fees Billed
|
|
$
|
176,000
|
|
|
$
|
189,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Consists of fees for professional services rendered in
connection with the audit of our financial statements for the
fiscal years ended June 30, 2007 and June 30, 2006;
the reviews of the financial statements included in each of our
quarterly reports on
Form 10-Q
during those fiscal years; and consents and assistance with
documents filed by the Company with the Securities and Exchange
Commission. |
|
(2) |
|
Consists of fees for tax advisory services in connection with
preparation of our federal and state tax returns and I.R.S.
audit. |
Our Audit Committee considered that the provision of the
services and the payment of the fees described above are
compatible with maintaining the independence of BDO Seidman, LLP.
6
Our Audit Committee is responsible for reviewing and
pre-approving any non-audit services to be performed by our
independent auditors. The Audit Committee has delegated certain
of its pre-approval authority to the Chairman of the Audit
Committee to act between meetings of the Audit Committee. Any
pre-approval given by the Chairman of the Audit Committee
pursuant to this delegation is presented to the full Audit
Committee at its next regularly scheduled meeting. The Audit
Committee or Chairman of the Audit Committee reviews and, if
appropriate, approves non-audit service engagements, taking into
account the proposed scope of the non-audit services, the
proposed fees for the non-audit services, whether the non-audit
services are permissible under applicable law or regulation and
the likely impact of the non-audit services on the independence
of the independent auditors.
Since the effective date of the Securities and Exchange
Commission rules requiring pre-approval of non-audit services on
May 6, 2003, each new engagement of our independent
auditors to perform non-audit services has been approved in
advance by the Audit Committee or the Chairman of the Audit
Committee pursuant to the foregoing procedures.
Audit
Committee Financial Expert
Our Board of Directors has determined that one of the members of
the Audit Committee, Robert E. Munzenrider, qualifies as an
audit committee financial expert as defined by the
rules of the Securities and Exchange Commission based on his
work experience and education.
The following table sets forth the name, age, current position
and principal occupation and employment during the past five
years of our executive officers:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Title
|
|
Emil H. Soika
|
|
|
69
|
|
|
President, Chief Executive Officer and Director
|
Drew M. Diaz
|
|
|
44
|
|
|
Vice President-Worldwide Sales
|
Michael T. Larsen
|
|
|
48
|
|
|
Vice President-Quality and Regulatory Affairs
|
Joseph P. Lester
|
|
|
57
|
|
|
Vice President and General Manager
|
Deborah A. Zane
|
|
|
53
|
|
|
Vice President-Marketing and Business Development
|
Joel D. Knudson
|
|
|
42
|
|
|
Vice President-Finance and Secretary
|
The term of office and past business experience of
Mr. Soika are described above under Election of
Directors.
Mr. Diaz was promoted from Director of International Sales
to Vice President-International Sales in May 1997 and was most
recently promoted to Vice President-Worldwide Sales in January
2002.
Mr. Larsen has served as Vice President-Quality and
Regulatory Affairs since October 2004. Mr. Larsen served as
our Vice President-Quality Control/Quality Assurance from
September 1990 until October 2004.
Mr. Lester was promoted to Vice President and General
Manager in October 2000 and joined our company as Vice
President-Operations in January 2000. Prior to joining the
Company, Mr. Lester was Vice President-Operations for
Siemens Medical Systems, Inc., a medical device company, from
April 1997 to January 2000.
Ms. Zane has served as our Vice President-Marketing and
Business Development since September 2001. From March 1999 to
September 2001, Ms. Zane served in various marketing
positions for the Company.
Mr. Knudson has served as our Vice President-Finance and
Secretary since September 2004. Mr. Knudson was our
Controller from February 2004 to September 2004. Prior to
joining the Company, Mr. Knudson was the Controller for
S.K. Williams Co., a metal finishing company, from November 2002
to February 2004 and, prior to that, was the Controller for
Anguil Environmental Systems, Inc., a manufacturer of pollution
control systems, from November 1994 until October 2002.
7
The following table sets forth information with respect to
beneficial ownership of our Common Stock as of
September 28, 2007 by (a) each of our directors,
(b) each named executive officer (as defined below),
(c) each person known by us to own beneficially more than
5% of our Common Stock, and (d) all of our directors and
executive officers as a group.
We have determined beneficial ownership in accordance with the
rules of the Securities and Exchange Commission. Unless
otherwise indicated, the persons and entities included in the
table have sole voting and investment power with respect to all
shares beneficially owned, except to the extent authority is
shared by spouses under applicable law. Shares of Common Stock
subject to options that are either currently exercisable or
exercisable within 60 days of September 28, 2007 are
treated as outstanding and beneficially owned by the option
holder for the purpose of computing the percentage ownership of
the option holder. However, these shares are not treated as
outstanding for the purpose of computing the percentage
ownership of any other person. The table lists the applicable
percentage ownership based on 12,318,985 shares outstanding
as of September 28, 2007.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
Name and Address of Beneficial Owner(1)
|
|
Shares Owned
|
|
|
Percent
|
|
|
Principal Stockholders:
|
|
|
|
|
|
|
|
|
Heartland Advisors, Inc.
|
|
|
1,427,400
|
(2)
|
|
|
11.6
|
%
|
BlueLine Partners, L.L.C.
|
|
|
1,368,700
|
(3)
|
|
|
11.1
|
%
|
White Pine Capital, LLC
|
|
|
670,325
|
(4)
|
|
|
5.4
|
%
|
Directors and Executive Officers:
|
|
|
|
|
|
|
|
|
Higgins D. Bailey
|
|
|
7,500
|
(5)
|
|
|
|
*
|
Jeffrey T. Barnes
|
|
|
|
|
|
|
|
*
|
N.C. Joseph Lai, Ph.D.
|
|
|
359,710
|
(6)
|
|
|
2.9
|
%
|
Emil H. Soika
|
|
|
140,191
|
(7)
|
|
|
1.1
|
%
|
William M. Moore
|
|
|
4,949
|
|
|
|
|
*
|
Robert E. Munzenrider
|
|
|
|
|
|
|
|
*
|
Drew M. Diaz
|
|
|
68,614
|
(8)
|
|
|
|
*
|
Joseph P. Lester
|
|
|
43,750
|
(9)
|
|
|
|
*
|
Deborah A. Zane
|
|
|
36,250
|
(10)
|
|
|
|
*
|
Joel D. Knudson
|
|
|
53,750
|
(11)
|
|
|
|
*
|
All directors and executive officers as a group (11 persons)
|
|
|
752,464
|
(12)
|
|
|
6.0
|
%
|
|
|
|
* |
|
Less than 1% |
|
(1) |
|
Unless otherwise indicated, the address of the beneficial owner
is 20925 Crossroads Circle, Suite 100, Waukesha, Wisconsin
53186; the address of Mr. Barnes is 222 Berkeley Street,
Suite 1650, Boston, Massachusetts
02116-3733;
the address of Dr. Lai is W302 N6117 Spence Road, Hartland,
WI 53029; the address of Mr. Moore is 4115 Blackhawk Plaza
Circle, Suite 100, Danville, California 94506; the address
of Dr. Bailey is 102 Celano Circle, Palm Desert, CA 92211;
and the address of Mr. Munzenrider is
1302 W. Aviator Circle, Payson, AZ 85541. |
|
(2) |
|
Heartland Advisors, Inc. (Heartland) filed a
Schedule 13G/A dated February 9, 2007 reporting that
as of December 31, 2006 Heartland was the beneficial owner
of 1,427,400 shares of Common Stock. Heartland shares
voting and investment power with respect to all such shares.
William J. Nasgovitz may be deemed to share voting and
investment power over all such shares, and each of Heartland and
Mr. Nasgovitz disclaim beneficial ownership of such shares.
Heartlands address is 789 North Water Street, Milwaukee,
Wisconsin 53202. |
|
(3) |
|
Pursuant to a Preliminary Schedule 14A filed on
November 17, 2006, BlueLine Capital Partners, L.P.
(BCP) and BlueLine Catalyst Fund VII, L.P.
(BlueLine Catalyst) hold 922,500 and
446,200 shares of the Companys Common Stock,
respectively. As the general partner of BCP, BlueLine Partners
L.L.C., a |
8
|
|
|
|
|
Delaware limited liability company (BlueLine
Delaware), may be deemed to be the beneficial owner of the
922,500 shares of Common Stock held by BCP. As general
partner of BlueLine Catalyst, BlueLine Partners, L.L.C., a
California limited liability company (BlueLine
California), may be deemed to be the beneficial owner of
the 446,200 shares of Common Stock held by BlueLine
Catalyst. Collectively, as of November 15, 2006, BCP,
BlueLine Catalyst, BlueLine Delaware and BlueLine California own
a total of 1,368,700 shares of Common Stock.
BlueLines address is 4115 Blackhawk Plaza Circle,
Suite 100, Danville, California 94506. |
|
(4) |
|
White Pine Capital, LLC (White Pine) filed a
Schedule 13G dated February 9, 2007 reporting that as
of December 31, 2006 White Pine was the beneficial owner of
670,325 shares of Common Stock. White Pine has sole voting
and investment power over all such shares. White Pines
address is 60 South Sixth Street, Suite 2530, Minneapolis,
Minnesota 55402. |
|
(5) |
|
Consists of 7,500 shares, which Mr. Bailey has the
right to acquire under currently exercisable options. |
|
(6) |
|
Consists of 154,710 shares owned directly by Dr. Lai;
116,000 shares owned of record by Dr. Lais wife;
85,000 shares owned by a trust of which Dr. Lai and
his wife are trustees; and 4,000 shares owned by the Lai
Family Foundation. |
|
(7) |
|
Consists of 87,000 shares owned directly by Mr. Soika,
37,500 shares which Mr. Soika has the right to acquire
under currently exercisable options and 15,691 shares in
Mr. Soikas account under the Criticare Systems, Inc.
Employee Stock Purchase Plan (the Purchase Plan). |
|
(8) |
|
Consists of 22,200 shares owned directly by Mr. Diaz,
44,000 shares which Mr. Diaz has the right to acquire
under currently exercisable options and 2,414 shares in
Mr. Diazs account under the Purchase Plan. |
|
(9) |
|
Consists of 43,750 shares, which Mr. Lester has the
right to acquire under currently exercisable options. |
|
(10) |
|
Consists of 36,250 shares, which Ms. Zane has the
right to acquire under currently exercisable options. |
|
(11) |
|
Consists of 53,750 shares, which Mr. Knudson has the
right to acquire under currently exercisable options. |
|
(12) |
|
Includes 255,500 shares of Common Stock the members of the
group have a right to acquire under currently exercisable
options and 18,105 shares in the accounts of the members of
the group under our Employee Stock Purchase Plan. |
SECTION 16(A)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as
amended (the Exchange Act), requires our officers
and directors, and persons who own more than 10% of a registered
class of our equity securities, to file with the Securities and
Exchange Commission reports of initial beneficial ownership on
Form 3 and reports of changes in beneficial ownership on
Forms 4 and 5. Officers, directors and greater than 10%
stockholders are required by regulations of the Securities and
Exchange Commission to furnish us with copies of all
Forms 3, 4 and 5 they file. Based solely on a review of the
copies of such forms furnished to us, or written representations
that no Forms 5 were required, we believe that during
fiscal 2006 all section 16(a) filing requirements
applicable to our officers, directors and greater than 10%
beneficial owners were complied with, except that
Mr. Barnes filed a Form 4 report on January 4,
2007 reporting transactions occurring on December 15, 2005
and December 19, 2006; Mr. Larsen filed a Form 4
report on February 12, 2007 reporting a transaction
occurring on February 5, 2007; and Mr. Knudson filed a
Form 4 report on February 12, 2007 reporting a
transaction occurring on February 5, 2007.
Compensation
Discussion and Analysis
This Compensation Discussion and Analysis addresses our
compensation policies and decisions for fiscal 2007 and the
first part of fiscal 2008 prior to the date of this proxy
statement for the five executive officers
9
listed below in the Summary Compensation Table. Throughout this
proxy statement, we refer to these five executive officers as
our named executive officers.
Our
Compensation Objectives
Our objective in establishing compensation arrangements for our
executive officers is to attract and retain key executives who
are important to our continued success through competitive
compensation arrangements but at a reasonable cost to Criticare
given our financial resources. Where appropriate, we also
provide financial incentives for performance in specific areas
of responsibility for an executive officer.
Competitive Compensation. We have not
established compensation levels based on benchmarking, and have
not conducted formal compensation surveys to determine the
compensation of our executive officers. While we have not
engaged external compensation consultants, management does
regularly evaluate, on an informal basis, the competitiveness of
the compensation for our executive officers with reference to
similarly-sized companies in our industry and in market area in
Southeastern Wisconsin. Management frequently receives
information regarding compensation at such companies through the
receipt of resumes from job applicants employed at such
companies and from other sources. Based on such information
regarding pay practices at other companies, we believe our
compensation practices are competitive in the marketplace.
Reasonable Cost. We also believe that we
achieve our compensation objectives at a reasonable cost to our
company and stockholders. Prior to fiscal 2006, we experienced a
number of years of losses and our management was focused on
developing and implementing initiatives to grow our business. In
these circumstances, management and our Board of Directors and
Compensation Committee looked to limit compensation costs to the
extent feasible consistent with our objectives of retention and
performance. Although we achieved profitability in both fiscal
2006 and fiscal 2007, we continue to believe that executive
compensation should come at a reasonable cost to our company and
stockholders.
Our
Compensation Process
Compensation for our executive officers and other senior
managers is reviewed and evaluated by the Compensation Committee
of our Board of Directors. The Compensation Committee then makes
recommendations to the Board for its final approval. Our
Compensation Committee currently consists of three independent
directors under the applicable standards of the American Stock
Exchange. Dr. Higgins D. Bailey is currently the Chairman
of our Compensation Committee and the other members of the
Compensation Committee are Jeffrey T. Barnes and William M.
Moore. Additional information regarding our Compensation
Committee is disclosed above under Directors
Meetings and Committees Compensation Committee
above.
Our Compensation Committee views compensation as an ongoing
process, and meets regularly throughout the year for purposes of
planning and evaluation. The Compensation Committee held two
meetings during fiscal 2007. The Compensation Committee receives
and reviews materials in advance of each meeting, including
materials that management believes will be helpful to the
Committee and well as materials specifically requested by
members of the Committee.
Our management plays a significant role in assisting the
Compensation Committee in its oversight of compensation.
Managements role includes assisting the Compensation
Committee with evaluating employee performance, establishing
individual performance targets and objectives, recommending
salary levels and option and other equity incentive grants, and
providing financial data on company performance, calculations
and reports on achievement of performance objectives, and other
information requested by the Committee. Our Chief Executive
Officer works with the Compensation Committee in making
recommendations regarding our overall compensation policies and
plans as well as specific compensation levels for our executive
officers and other key employees, other than the Chief Executive
Officer. Members of management who were present during
Compensation Committee meetings in fiscal 2007 and 2008 included
the Chief Executive Officer and the Chief Financial Officer. The
Compensation Committee makes all decisions regarding the
compensation of the Chief Executive Officer without the Chief
Executive Officer or any other member of management present.
10
The Compensation Committees charter requires that we
provide the Committee with adequate funding to engage any
compensation consultants or other advisers the Committee wishes
to engage. During fiscal 2007 and 2008 to date, the Compensation
Committee did not engage any consultants to assist it in
reviewing our compensation practices and levels.
Components
of Executive Compensation
For executive officers, the primary components of total
compensation continue to be base salary, commissions, bonuses
and long-term incentive compensation in the form of stock
options.
Base Salary. Base salary is a key component of
executive compensation. In determining base salaries, the
Compensation Committee considers the executive officers
qualifications and experience, the executive officers
responsibilities, the executive officers past performance,
and the executive officers goals and objectives.
Our Compensation Committee reviews base salaries on a periodic
(although not necessarily annual) basis. Generally, changes in
base salaries for our named executive officers (other than our
Chief Executive Officer) are considered by the Compensation
Committee at the initiative of our Chief Executive Officer.
Given our limited financial resources and our focus on returning
Criticare to profitability, increases in the base salaries of
our executive officers have generally been modest in recent
years:
|
|
|
|
|
The base salary of Emil Soika, our Chief Executive Officer, in
fiscal 2007 of $262,000 has increased by $37,000 over his base
salary of $225,000 in fiscal 2002, an increase of 16% over a
period of six years.
|
|
|
|
The base salary of Drew M. Diaz, our Vice President-Worldwide
Sales, has remained at $110,000 per year since fiscal 2002 and
the base salary of Deborah A. Zane, our Vice President-Marketing
and Business Development, has increased by $10,000 (8%) from
$120,000 in fiscal 2002 to $130,000 in fiscal 2007. As described
below under Performance-Based Commissions and
Bonuses, a significant portion of the compensation to
Mr. Diaz and Ms. Zane is based on sales commissions.
|
|
|
|
The base salary of Joseph P. Lester, our Vice President and
General Manager, has increased by $6,000 (4%) from $140,000 in
fiscal 2003 to $146,000 in fiscal 2007. Mr. Lester also
receives commissions and a performance-based bonus.
|
|
|
|
The base salary level of Joel D. Knudson, our Vice
President-Finance, has increased by $40,000 (36%) from $110,000
in fiscal 2005 to $150,000 in fiscal 2007. Mr. Knudson was
promoted to his position in fiscal 2005, which has involved a
significant increase in his responsibilities.
|
There were no changes in the base salary levels of our named
executive officers during fiscal 2007, other than
Mr. Knudson who received an increase from $140,000 to
$150,000.
Performance-Based Commissions and
Bonuses. Three of our named executive officers,
Drew M. Diaz, Deborah A. Zane and Joseph P. Lester, receive
sales commissions in addition to a fixed base salary. Joseph P.
Lester also receives an annual bonus based upon manufacturing
cost-savings achieved for specific product programs.
Drew M. Diaz, our Vice President-Worldwide Sales, oversees our
sales staff and international distributor network. As is typical
in our industry for management with sales responsibility, a
substantial portion of Mr. Diazs compensation
consists of an uncapped commission on sales completed by any
persons supervised by Mr. Diaz. In fiscal 2007,
Mr. Diaz received total commissions of $165,235 compared to
his fixed base salary of $110,000, and his commissions
constituted 57% of his total compensation of $289,670.
Deborah A. Zane, our Vice President-Marketing and Business
Development, is responsible for developing our business with
original equipment manufacturers (OEMs). We view OEM agreements
as a critical component to our strategy to develop products for
highly technical niche markets, and the OEM business has been a
significant driver of our growth in recent years. Ms. Zane
receives uncapped commissions with respect to the sales she
brings to Criticare, at rates that vary depending on the type of
product and the OEM. In fiscal
11
2007, Ms. Zane received total commissions of $118,275
compared to her fixed base salary of $130,000, and her
commissions constituted 45% of her total compensation of
$263,474.
Joseph P. Lester, our Vice President and General Manager, is
responsible for overseeing the manufacturing process for our
products, and receives a bonus for the cost reductions achieved
for new products once in full production. When Criticare
introduces a new product, initial production is usually launched
at our main facility in Waukesha, Wisconsin.
Mr. Lesters bonus is only applicable to cost
reductions achieved once the initial production process is
completed and the product is ready for full production, and at
that point Mr. Lester receives a bonus based on reducing
costs for materials and labor, including, where appropriate,
outsourcing production. In fiscal 2007, Mr. Lester received
a bonus $14,356. Mr. Lesters duties also include
serving as territory manager for Taiwan and China, and in that
capacity he oversees sales made by our distributor in that
region. Mr. Lester receives commissions relating to such
sales, which commissions totaled $3,917 in fiscal 2007.
Mr. Lesters total commissions and bonus constituted
10% of his total compensation of $177,786 in fiscal 2007.
Discretionary Bonuses. Our named executive
officers are eligible to receive discretionary cash bonuses.
Discretionary bonuses allow us to recognize extraordinary
individual performance by our executive officers and to have the
flexibility to maintain competitive compensation when needed. No
discretionary bonuses were awarded for fiscal 2007.
Equity-Based Compensation. We believe that
equity compensation is an effective means of aligning the
long-term interests of our employees, including our executive
officers, with our stockholders. Our 2003 Stock Option Plan
authorizes the Compensation Committee to issue both stock
options and restricted stock, as well as other forms of equity
incentive compensation. To date, awards to our executive
officers under the 2003 Stock Option Plan have consisted solely
of stock options.
In determining the total size of equity awards, the Compensation
Committee considers various factors such as the outstanding
number of stock options, the amount of additional shares
available for issuance under the 2003 Stock Option Plan, the
level of responsibility of the proposed recipient and his or her
performance, the percent of the outstanding shares of our common
stock represented by outstanding options and the expense to
Criticare under FAS 123R. We do not have a practice of
making regular annual or other periodic equity grants to our
executive officers. In fact, we have not granted significant
equity awards to our executive officers since fiscal 2004, and
Mr. Knudson and Mr. Diaz were the only named executive
officers to receive a grant in fiscal 2007. We expect to
consider making grants to our executive officers in fiscal 2008.
At that time, we expect that the Compensation Committee will
review the appropriate form of the grants (whether stock
options, restricted stock or stock appreciation rights) in view
of the factors described above.
Our prior option grants to our executive officers have generally
incorporated the following terms:
|
|
|
|
|
the term of the option does not exceed ten years;
|
|
|
|
the grant price is not less than the closing market price of our
common stock on the date of grant; and
|
|
|
|
options vest 25% per year over the first four years of the term
of the option.
|
One of our named executive officers, Joel D. Knudson, received a
grant of an option to purchase 20,000 shares of common
stock on February 5, 2007, which was the anniversary date
of Mr. Knudsons original employment by Criticare and
was made in recognition of Mr. Knudsons efforts,
particularly in the area of improving the Companys balance
sheet fundamentals during fiscal 2007. This option has an
exercise price of $3.45 per share, a ten-year term and vests 25%
per year on the anniversary of the date of grant over the first
four years of the term of the option. This option is a
non-qualified stock option under the Internal Revenue Code with
an exercise price equal to the closing price of our common stock
on the date of grant. As a result, this stock option will only
have value to the named executive officer if our stock price
increases after the date of grant. The option had a grant date
fair value $44,708 as determined pursuant to
FAS No. 123R. Drew M. Diaz also received a grant of an
option to purchase 4,000 shares of common stock on
March 26, 2007. This grant was the extension of a grant
issued on April 6, 2003 that was set to expire with an
exercise price of $3.08 per share. The original option had a
grant date fair value $2,174 as determined pursuant to
12
FAS No. 123R, which will be reversed as a forfeiture
pursuant to FAS 123R. The new option has an exercise price
of $3.71 per share, a two-year term and vested immediately upon
grant. This option is a non-qualified stock option under the
Internal Revenue Code with an exercise price equal to the
closing price of our common stock on the date of grant. As a
result, this stock option will only have value to the named
executive officer if our stock price increases after the date of
grant. The option had a grant date fair value $4,676 as
determined pursuant to FAS No. 123R.
Perquisites and Other Compensation. Our named
executive officers participate in other benefit plans generally
available to all employees on the same terms as similarly
situated employees, including participation in health,
disability, life insurance and 401(k) plans. In addition, our
executive officers each receive group term life insurance
coverage up to $272,000 and automobile allowance payments or the
personal use of an automobile leased by Criticare. Additionally,
Mr. Diaz receives tax services paid for by us. These
benefits are included in the Summary Compensation Table in the
All Other Compensation column.
Change
of Control and Severance Benefits
We have entered into an employment agreement with each of our
named executive officers. The employment agreements set forth
the current terms and conditions for employment of the executive
officers, and include severance benefits, and noncompetition and
confidentiality covenants restricting the executives
activities both during and for a period of time after
employment. These agreements are summarized in more detail below
under Employment Agreements and
Post-Employment Compensation.
We believe the severance benefits provided to our executive
officers are a key benefit in retaining the services of our
executive officers. These benefits provide post-employment
security, including following a change of control, at a
reasonable cost to Criticare and its stockholders.
Tax
and Accounting Considerations
Deductibility of Executive
Compensation. Section 162(m) of the Internal
Revenue Code generally disallows a tax deduction to a public
corporation for non-performance-based compensation over
$1,000,000 paid for any fiscal year to each of the individuals
who were, at the end of the fiscal year, the corporations
chief executive officer and the three other most highly
compensated executive officers (other than the Chief Financial
Officer). Through the end of fiscal 2007, we do not believe that
any of the compensation paid to our executive officers exceeded
the limit on deductibility in Section 162(m). Our 2003
Stock Option Plan is intended to satisfy the requirements for
performance-based compensation under
Section 162(m) of the Code, including the requirement that
such plan be approved by our stockholders. As a result, we
believe that awards under this plan satisfy the requirements for
performance-based compensation under
Section 162(m) and, accordingly, do not count against the
$1,000,000 limit and are deductible by us. Other compensation
paid or imputed to individual executive officers covered by
Section 162(m) may not satisfy the requirements for
performance-based compensation and may cause
non-performance-based compensation to exceed the $1,000,000
limit, and would then not be deductible by us to the extent in
excess of the $1,000,000 limit. Although the Compensation
Committee designs certain components of executive compensation
to preserve income tax deductibility, it believes that it is not
in the shareholders interest to restrict the Compensation
Committees discretion and flexibility in developing
appropriate compensation programs and establishing compensation
levels and, in some instances, the Compensation Committee may
approve compensation that is not fully deductible.
Nonqualified Deferred
Compensation. Section 409A of the Code was
signed into law on October 22, 2004, changing the tax rules
applicable to nonqualified deferred compensation arrangements.
We expect to amend the severance benefit provisions of the
employment agreements with our executive officers before
December 31, 2007 to provide that these benefits will not
be subject to the excise tax under Section 409A. These are
expected to be minor amendments which will not increase the
severance benefits of the executive officers. We do not believe
that we have any other nonqualified deferred compensation
arrangements with any of our executive officers that will be
subject to the excise tax under this law.
13
Accounting for Stock-Based
Compensation. Beginning on July 1, 2005, we
began accounting for stock-based payments, including stock
options under our 2003 Stock Option Plan, in accordance with the
requirements of FAS 123R. The Compensation Committee
considers the impact of the expense to Criticare under
FAS 123R, among other factors, in making its decisions with
respect to stock option grants.
Report
of the Compensation Committee
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis set forth in this proxy
statement with our management and, based on such review and
discussions with management, the Compensation Committee
recommended to our Board of Directors that the Compensation
Discussion and Analysis be included in this proxy statement.
COMPENSATION COMMITTEE:
Dr. Higgins D. Bailey (Chairman)
Jeffrey T. Barnes
William M. Moore
Summary
Compensation Table
The following table provides information for fiscal 2007
concerning the compensation paid by us to the person who served
as our principal executive officer in fiscal 2007, the person
who served as our principal financial officer in fiscal 2007 and
our three other most highly compensated executive officers based
on their total compensation in fiscal 2007. We refer to these
five executive officers as our named executive
officers in this proxy statement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal
|
|
|
|
|
|
Option
|
|
All Other
|
|
|
Name and Principal Position
|
|
Year
|
|
Salary
|
|
Bonus
|
|
Awards(1)
|
|
Compensation(2)
|
|
Total
|
|
Emil H. Soika, President and Chief Executive Officer
|
|
|
2007
|
|
|
$
|
262,000
|
|
|
$
|
0
|
|
|
$
|
5,980
|
|
|
$
|
9,132
|
|
|
$
|
277,112
|
|
Joel D. Knudson, Vice President-Finance
|
|
|
2007
|
|
|
$
|
144,167
|
|
|
$
|
0
|
|
|
$
|
35,776
|
|
|
$
|
9,111
|
|
|
$
|
189,054
|
|
Drew M. Diaz, Vice President-Worldwide Sales
|
|
|
2007
|
|
|
$
|
277,350
|
(3)
|
|
$
|
0
|
|
|
$
|
6,014
|
|
|
$
|
6,306
|
|
|
$
|
289,670
|
|
Joseph P. Lester, Vice President and General Manager
|
|
|
2007
|
|
|
$
|
149,917
|
(4)
|
|
$
|
14,356
|
|
|
$
|
2,990
|
|
|
$
|
10,523
|
|
|
$
|
177,786
|
|
Deborah A. Zane, Vice President-Marketing and Business
Development
|
|
|
2007
|
|
|
$
|
248,275
|
(5)
|
|
$
|
0
|
|
|
$
|
4,186
|
|
|
$
|
11,013
|
|
|
$
|
263,474
|
|
Explanatory Notes for Summary Compensation Table:
|
|
|
(1) |
|
These amounts reflect the dollar value of the compensation cost
of all outstanding option awards recognized over the requisite
service period, computed in accordance with FAS 123(R) and,
therefore, includes amounts from awards granted prior to fiscal
2007 that vested in fiscal 2007. We calculated the fair value of
option awards using the Black-Sholes option pricing model. For
purposes of this calculation, the impact of forfeitures is
excluded until they actually occur. The other assumptions made
in valuing the option awards are included under the caption
Stockholders Equity in the Notes to our
Consolidated Financial Statements in the fiscal year 2007 Annual
Report on
Form 10-K
and such information is incorporated herein by reference. |
|
(2) |
|
The table below shows the components of this column, which
include our match for each individuals 401(k) plan
contributions, the cost of premiums paid by us for term life
insurance under which the named executive officer is a
beneficiary and perquisites consisting of an automobile
allowance for Mr. Lester, Mr. Knudson and
Ms. Zane, the value of the personal use of automobiles
leased by us for Mr. Soika and Mr. Diaz, and tax
services received by Mr. Diaz that were paid by us. |
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total All Other
|
Name
|
|
401(k) Match
|
|
Life Insurance
|
|
Perquisites
|
|
Compensation
|
|
Emil H. Soika
|
|
|
$4,400
|
|
|
|
$3,383
|
|
|
|
$1,349
|
|
|
|
$9,132
|
|
Joel D. Knudson
|
|
|
$2,845
|
|
|
|
$266
|
|
|
|
$6,000
|
|
|
|
$9,111
|
|
Drew M. Diaz
|
|
|
$4,400
|
|
|
|
$266
|
|
|
|
$1,640
|
|
|
|
$6,306
|
|
Joseph P. Lester
|
|
|
$3,377
|
|
|
|
$1,146
|
|
|
|
$6,000
|
|
|
|
$10,523
|
|
Deborah A. Zane
|
|
|
$4,400
|
|
|
|
$613
|
|
|
|
$6,000
|
|
|
|
$11,013
|
|
|
|
|
(3) |
|
Represents a fixed salary of $110,000, $2,115 paid in lieu of
vacation time based on seniority and commissions of $165,235
paid by us to Mr. Diaz. |
|
(4) |
|
Represents a fixed salary of $146,000 and commissions of $3,917
paid by us to Mr. Lester. |
|
(5) |
|
Represents a fixed salary of $130,000 and commissions of
$118,275 paid by us to Ms. Zane. |
Grants
of Plan-Based Awards
The following table sets forth information regarding all
incentive plan awards that were granted to the named executive
officers during fiscal year 2007, consisting of a stock option
award subject to FAS 123(R). No other equity or non-equity
incentive plan awards were made to named executive officers
during fiscal 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other Option
|
|
|
|
Grant Date
|
|
|
|
|
Awards: Number of
|
|
|
|
Fair Value
|
|
|
Grant
|
|
Securities
|
|
Exercise
|
|
of Option
|
Name
|
|
Date
|
|
Underlying Options
|
|
Price
|
|
Award(3)
|
|
Emil H. Soika
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joel D. Knudson(1)
|
|
02/05/07
|
|
|
20,000
|
|
|
$
|
3.45
|
|
|
$
|
44,708
|
|
Drew M. Diaz(2)
|
|
03/26/07
|
|
|
4,000
|
|
|
$
|
3.71
|
|
|
$
|
4,676
|
|
Joseph P. Lester
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deborah A. Zane
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The common stock option vests pro rata over a four-year period
on each of February 5, 2008, February 5, 2009,
February 5, 2010 and February 5, 2011 and expires on
February 5, 2017. |
|
(2) |
|
The common stock option vested on March 26, 2007 and
expires on March 26, 2009. |
|
(3) |
|
The value of the award is based upon the grant date fair value
of the award determined pursuant to FAS 123R. Generally,
the grant date fair value is the amount that we would expense in
our financial statements over the awards vesting schedule.
See Stockholders Equity in the Notes to our
Consolidated Financial Statements in the fiscal year 2007 Annual
Report on From
10-K for the
assumptions we relied on in determining the value of the award. |
15
Outstanding
Equity Awards at Fiscal Year-End
The following table sets forth information on outstanding option
awards held by the named executive officers at June 30,
2007, including the number of shares underlying both exercisable
and unexercisable portions of each stock option as well as the
exercise price and expiration date of each outstanding option.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
|
Unexercised
|
|
Unexercised
|
|
|
|
|
|
|
Options
|
|
Options
|
|
Option Exercise
|
|
Option Expiration
|
Name
|
|
(#) Exercisable
|
|
(#) Unexercisable
|
|
Price ($)
|
|
Date
|
|
Emil H. Soika
|
|
|
37,500
|
|
|
|
12,500
|
|
|
|
3.05
|
|
|
|
06/07/14
|
(1)
|
Joel D. Knudson
|
|
|
1,500
|
|
|
|
500
|
|
|
|
4.37
|
|
|
|
02/02/14
|
(2)
|
|
|
|
2,250
|
|
|
|
750
|
|
|
|
3.05
|
|
|
|
06/07/14
|
(1)
|
|
|
|
25,000
|
|
|
|
25,000
|
|
|
|
2.61
|
|
|
|
08/20/14
|
(3)
|
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
3.70
|
|
|
|
01/17/15
|
(4)
|
|
|
|
1,250
|
|
|
|
3,750
|
|
|
|
5.19
|
|
|
|
09/09/15
|
(5)
|
|
|
|
|
|
|
|
20,000
|
|
|
|
3.45
|
|
|
|
02/05/17
|
(6)
|
Drew M. Diaz
|
|
|
4,000
|
|
|
|
|
|
|
|
3.71
|
|
|
|
03/26/09
|
(7)
|
|
|
|
10,000
|
|
|
|
|
|
|
|
2.88
|
|
|
|
01/30/08
|
(8)
|
|
|
|
30,000
|
|
|
|
10,000
|
|
|
|
3.05
|
|
|
|
06/07/14
|
(1)
|
Joseph P. Lester
|
|
|
25,000
|
|
|
|
|
|
|
|
2.88
|
|
|
|
01/30/08
|
(8)
|
|
|
|
18,750
|
|
|
|
6,250
|
|
|
|
3.05
|
|
|
|
06/07/14
|
(1)
|
Deborah A. Zane
|
|
|
10,000
|
|
|
|
|
|
|
|
2.88
|
|
|
|
01/30/08
|
(8)
|
|
|
|
26,250
|
|
|
|
8,750
|
|
|
|
3.05
|
|
|
|
06/07/14
|
(1)
|
|
|
|
(1) |
|
The common stock option vests pro rata over a four-year period
on each of June 7, 2005, June 7, 2006, June 7,
2007 and June 7, 2008. |
|
(2) |
|
The common stock option vests pro rata over a four-year period
on each of February 2, 2005, February 2, 2006,
February 2, 2007 and February 2, 2008. |
|
(3) |
|
The common stock option vests pro rata over a four-year period
on each of August 20, 2005, August 20, 2006,
August 20, 2007 and August 20, 2008. |
|
(4) |
|
The common stock option vests pro rata over a four-year period
on each of January 17, 2006, January 17, 2007,
January 17, 2008 and January 17, 2009. |
|
(5) |
|
The common stock option vests pro rata over a four-year period
on each of September 9, 2006, September 9, 2007,
September 9, 2008 and September 9, 2009. |
|
(6) |
|
The common stock option vests pro rata over a four-year period
on each of February 5, 2008, February 5, 2009,
February 5, 2010 and February 5, 2011. |
|
(7) |
|
The common stock option vested on the date of grant,
March 26, 2007. |
|
(8) |
|
The common stock option vested pro rata over a four-year period
on each of January 30, 2004, January 30, 2005,
January 30, 2006 and January 30, 2007. |
None of our named executive officers exercised any stock options
during fiscal 2007.
Effective September 28, 2006, we entered into an amended
and restated employment agreement with Drew M. Diaz, Vice
President-Worldwide Sales; effective September 1, 2005, we
entered into an amended and
16
restated employment agreement with Emil H. Soika, President,
Chief Executive Officer and Director; effective May 18,
2000, we entered into an employment agreement with Joseph P.
Lester, Vice President and General Manager; effective
November 10, 2006, we entered into an amended and restated
employment agreement with Deborah A. Zane, Vice
President-Marketing and Business Development; and effective
August 8, 2005, we entered into an employment agreement
with Joel D. Knudson, Vice President-Finance and Secretary. All
of the employment agreements were amended effective
September 28, 2006 to replace the definition of
change of control with a new, more complete
definition.
The terms of these employment agreements include the following:
|
|
|
|
|
each executive officers base salary is reviewed annually
within 30 days prior to the end of each fiscal year;
|
|
|
|
each of these executive officers is entitled to participate in
our bonus plans and stock option plan;
|
|
|
|
each of these executive officers is eligible to participate in
health insurance benefits, group life and disability insurance
benefits;
|
|
|
|
each of Mr. Soika, Mr. Diaz, Mr. Lester and
Ms. Zane has agreed not to compete with us during
employment and not to our solicit customers or employees for a
period of 12, 12, 18 and 12 months, respectively, after any
voluntary termination of employment or any termination by us
with or without cause;
|
|
|
|
each of the named executive officers have agreed to maintain the
confidentiality of our financial statements and other financial
information; and
|
|
|
|
each employment agreement contains severance benefits, which are
summarized below under Executive
Compensation-Post-Employment Compensation.
|
Post-Employment
Compensation
401(k)
Plan Benefits
Our executive officers are eligible to participate in our 401(k)
plan on the same terms as our other employees. In any plan year,
we will contribute to each participant a matching contribution
equal to 50% on the first 4% of an employees annual wages.
All of our executive officers participated in our 401(k) plan
during fiscal 2007 and received matching contributions.
Nonqualified
Deferred Compensation
We do not currently provide any nonqualified deferred
compensation or other deferred compensation plans.
Potential
Payments Upon Termination or Change of Control
We have entered into employment agreements with each of our
named executive officers that provide for severance benefits in
the event of a termination of their employment by the Company
without cause (as defined in the employment agreements),
regardless of whether termination of employment is in connection
with a change of control (as defined in the employment
agreements). In addition, our named executive officers are also
entitled to severance benefits in the event of a voluntary
termination of employment by the executive officer at any time
following a change of control, provided that in the cases of
Mr. Knudson and Mr. Lester, the executive officer must
remain employed for at least three months after the change of
control. Under each of the employment agreements, a material
reduction in the executive officers responsibilities or
salary or the relocation of the executive officer to a location
that is greater than 30 miles from the executive
officers then place of employment are deemed to qualify as
a termination of employment by the Company without cause.
17
The severance benefits provided to our named executive officers
under their employment agreements include the following:
|
|
|
|
|
continued payment of compensation for 30 months after the
date of termination in case of Mr. Soika, 24 months
for Mr. Diaz, 18 months for Mr. Lester,
15 months for Ms. Zane, and 12 months for
Mr. Knudson;
|
|
|
|
continuation of health, life and disability insurance benefits
for 30 months after the date of termination in case of
Mr. Soika, 24 months for Mr. Diaz, 18 months
for Mr. Lester, 15 months for Ms. Zane, and
12 months for Mr. Knudson;
|
|
|
|
the transfer of ownership of a company car to Mr. Soika at
the end of the lease term at our cost, and continued use of a
company car (or an equivalent car allowance) for 24 months
after the date of termination in case of Mr. Diaz,
18 months for Mr. Lester, 15 months for
Ms. Zane and 12 months for Mr. Knudson; and
|
|
|
|
payment of Mr. Soikas real estate brokers
commission (subject to a maximum rate or 6% of the sales price)
arising from the sale of Mr. Soikas Wisconsin
residence and his professional packing and moving expenses
associated with Mr. Soika relocating to a new residence.
|
The following table sets forth the compensation that each of our
named executive officers would have been eligible to receive if
the applicable executive officers employment had been
terminated as of June 30, 2007 under circumstances
requiring payment of severance benefits as described above.
Potential
Severance Under Employment Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Use of Car/Car
|
|
|
|
|
|
|
|
Name
|
|
Compensation(1)
|
|
|
Benefits(2)
|
|
|
Allowance
|
|
|
Relocation Costs
|
|
|
Total
|
|
|
Emil H. Soika
|
|
$
|
655,000
|
|
|
$
|
23,150
|
|
|
$
|
26,524
|
|
|
$
|
31,000
|
|
|
$
|
735,674
|
|
Joel D. Knudson
|
|
$
|
150,000
|
|
|
$
|
10,383
|
|
|
$
|
6,000
|
|
|
|
|
|
|
$
|
166,383
|
|
Drew M. Diaz
|
|
$
|
583,814
|
|
|
$
|
27,561
|
|
|
$
|
12,000
|
|
|
|
|
|
|
$
|
623,375
|
|
Joseph P. Lester
|
|
$
|
247,297
|
|
|
$
|
7,117
|
|
|
$
|
9,000
|
|
|
|
|
|
|
$
|
263,414
|
|
Deborah A. Zane
|
|
$
|
301,012
|
|
|
$
|
6,158
|
|
|
$
|
7,500
|
|
|
|
|
|
|
$
|
314,670
|
|
|
|
|
(1) |
|
Compensation consists of base salary and, where applicable,
commissions and bonus amounts for the year preceding the date of
termination. |
|
(2) |
|
The benefits consist of expenses for the continuation of health,
disability and life insurance coverage for the applicable period. |
As described above, our 2003 Stock Option Plan also provides for
immediate vesting of all outstanding options and the lapse of
any forfeiture provisions or other restrictions on outstanding
shares of restricted stock upon a change of control of
Criticare. The following table sets forth the unvested stock
options held by our named executive officers as of June 30,
2007 that would become vested in the event of a change of
control of Criticare.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
Unrealized Value of
|
|
|
|
Underlying Unvested
|
|
|
Unvested
|
|
Name
|
|
Options
|
|
|
Options(1)
|
|
|
Emil H. Soika
|
|
|
12,500
|
|
|
$
|
3,750
|
|
Joel D. Knudson
|
|
|
60,000
|
|
|
$
|
18,725
|
|
Drew M. Diaz
|
|
|
10,000
|
|
|
$
|
3,000
|
|
Joseph P. Lester
|
|
|
6,250
|
|
|
$
|
1,875
|
|
Deborah A. Zane
|
|
|
8,750
|
|
|
$
|
2,625
|
|
|
|
|
(1) |
|
Unrealized value equals the closing market value of our common
stock as of June 29, 2007, minus the exercise price,
multiplied by the number of unvested shares of our common stock
as of such date. The closing market value of our Common Stock on
June 29, 2007 was $3.35. |
18
Effective March 31, 2006, our outside directors receive an
annual fee of $24,000 and the Chairman of the Board, currently
Dr. Higgins D. Bailey, receives an annual fee of $30,000.
Effective April 1, 2006, directors who are also our
officers or employees do not receive fees for service on our
Board. Our director fees are paid quarterly. In addition, our
directors are reimbursed for out-of-pocket expenses incurred in
attending meetings of the Board.
We have adopted the Criticare Systems, Inc. 2003 Stock Option
Plan, which allows us to grant to our directors, officers and
employees and to certain other of our service providers stock
options, shares of restricted stock and stock appreciation
rights. Under the 2003 Stock Option Plan and in connection with
their appointment to the Board of Directors, on April 5,
2007, each of Mr. Moore and Mr. Munzenrider was
granted options to purchase 20,000 shares of our common
stock with an exercise price of $3.76 per share. Each of these
stock options vest pro rata over a four-year period on each of
April 5, 2008, April 5, 2009, April 5, 2010 and
April 5, 2011.
Director
Summary Compensation Table
The following table summarizes the director compensation for
fiscal year 2007 for all of our non-employee directors. For
fiscal 2007, Mr. Soika did not receive any additional
compensation for his services as a director beyond the amounts
previously disclosed in the Summary Compensation Table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
Option Awards
|
|
|
All Other
|
|
|
|
|
Name
|
|
Paid in Cash
|
|
|
(Notes 1 and 2)
|
|
|
Compensation
|
|
|
Total
|
|
|
Higgins D. Bailey
|
|
$
|
30,000
|
|
|
$
|
1,196
|
|
|
|
|
|
|
$
|
31,196
|
|
Jeffrey T. Barnes
|
|
$
|
24,000
|
|
|
$
|
0
|
|
|
|
|
|
|
$
|
24,000
|
|
N.C. Joseph Lai
|
|
$
|
24,000
|
|
|
$
|
0
|
|
|
|
|
|
|
$
|
24,000
|
|
William M. Moore
|
|
$
|
6,000
|
|
|
$
|
5,958
|
|
|
|
|
|
|
$
|
11,958
|
|
Robert E. Munzenrider
|
|
$
|
6,000
|
|
|
$
|
5,958
|
|
|
|
|
|
|
$
|
11,958
|
|
Explanatory Notes for Director Summary Compensation Table:
|
|
|
(1) |
|
These amounts reflect the dollar value of the compensation cost
of all outstanding option awards recognized over the requisite
service period, computed in accordance with FAS 123(R) and,
therefore, includes amounts from awards granted prior to fiscal
2007 that vested in fiscal 2007. We calculated the fair value of
option awards using the Black-Sholes option pricing model. For
purposes of this calculation, the impact of forfeitures is
excluded until they actually occur. The other assumptions made
in valuing the option awards are included under the caption
Stockholders Equity in the Notes to our
Consolidated Financial Statements in the fiscal year 2007 Annual
Report on
Form 10-K
and such information is incorporated herein by reference. |
|
(2) |
|
The following table identifies the aggregate number of shares of
Common Stock subject to outstanding common stock options as of
June 30, 2007 held by each of our outside directors: |
|
|
|
|
|
|
|
Number of Shares
|
|
|
|
of Common Stock
|
|
|
|
Subject to Common Stock
|
|
|
|
Options Outstanding
|
|
Name of Outside Director
|
|
as of June 30, 2007
|
|
|
Higgins D. Bailey
|
|
|
10,000
|
|
Jeffrey T. Barnes
|
|
|
|
|
N.C. Joseph Lai
|
|
|
|
|
William M. Moore
|
|
|
20,000
|
|
Robert E. Munzenrider
|
|
|
20,000
|
|
19
The following table sets forth information regarding stock
option awards that were granted to our outside directors during
fiscal 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other Option Awards:
|
|
|
|
|
|
Grant Date Fair
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
Value of Option
|
|
Name
|
|
Grant Date
|
|
|
Underlying Options(1)
|
|
|
Exercise Price
|
|
|
Award(2)
|
|
|
Higgins D. Bailey
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jeffrey T. Barnes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N.C. Joseph Lai
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William M. Moore
|
|
|
04/05/07
|
|
|
|
20,000
|
|
|
$
|
3.76
|
|
|
$
|
48,542
|
|
Robert E. Munzenrider
|
|
|
04/05/07
|
|
|
|
20,000
|
|
|
$
|
3.76
|
|
|
$
|
48,542
|
|
|
|
|
(1) |
|
The common stock option vests pro rata over a four-year period
on each of April 5, 2008, April 5, 2009, April 5,
2010 and April 5, 2011 and expires on April 5, 2017. |
|
(2) |
|
The value of the award is based upon the grant date fair value
of the award determined pursuant to FAS 123R. Generally,
the grant date fair value is the amount that we would expense in
our financial statements over the awards vesting schedule.
See Stockholders Equity in the Notes to our
Consolidated Financial Statements in the fiscal year 2007 Annual
Report on
Form 10-K
for the assumptions we relied on in determining the value of the
award. |
As described above, our 2003 Stock Option Plan provides for
immediate vesting of all outstanding options upon a change of
control of Criticare. The following table sets forth the
unvested stock options held by our outside directors as of
June 30, 2007 that would become vested in the event of a
change of control of Criticare.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
Unrealized Value of
|
|
|
|
Underlying
|
|
|
Unvested
|
|
Name
|
|
Unvested Options
|
|
|
Options(1)
|
|
|
Higgins D. Bailey
|
|
|
2,500
|
|
|
$
|
750
|
|
Jeffrey T. Barnes
|
|
|
|
|
|
|
|
|
N.C. Joseph Lai
|
|
|
|
|
|
|
|
|
William M. Moore
|
|
|
20,000
|
|
|
$
|
0
|
(2)
|
Robert E. Munzenrider
|
|
|
20,000
|
|
|
$
|
0
|
(2)
|
|
|
|
(1) |
|
Unrealized value equals the closing market value of our common
stock as of June 29, 2007, minus the exercise price,
multiplied by the number of unvested shares of our common stock
as of such date. The closing market value of our common stock on
June 29, 2007 was $3.35. |
|
(2) |
|
The unrealized value of these common stock options is $0 because
the exercise price exceeds the closing market price of our
common stock on June 29, 2007. |
RATIFICATION
OF APPOINTMENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
Our Audit Committee has appointed BDO Seidman, LLP as the
independent registered public accounting firm to audit our
consolidated financial statements for the fiscal year ending
June 30, 2008. Unless otherwise directed, proxies will be
voted in FAVOR of the ratification of such appointment.
Although this appointment is not required to be submitted to a
vote of stockholders, our Board believes it appropriate as a
matter of policy to request that the stockholders ratify the
appointment. If stockholder ratification is not received, our
Board will reconsider the appointment. It is expected that a
representative of BDO Seidman, LLP will be present at the Annual
Meeting and will have the opportunity to make a statement if he
or she desires to do so and will be available to respond to
appropriate questions.
20
PROPOSALS FOR
2008 ANNUAL MEETING
Proposals which stockholders intend to present at the 2008
Annual Meeting of Stockholders pursuant to
Rule 14a-8
under the Exchange Act must be received at our principal offices
no later than July 2, 2008 (120 days prior to the
anniversary date of the mailing of this Proxy Statement) for
inclusion in the proxy material for that meeting. Such proposals
must be in compliance with applicable laws and regulations in
order to be considered for possible inclusion in the proxy
statement and form of proxy for that meeting.
Proposals submitted other than pursuant to
Rule 14a-8
will be considered untimely if received after September 15,
2008 and the Company will not be required to present any such
proposal at the 2008 Annual Meeting of Stockholders. If the
Board of Directors decides to present a proposal despite its
untimeliness, the people named in the proxies solicited by the
Board of Directors for the 2008 Annual Meeting of Stockholders
will have the right to exercise discretionary voting power with
respect to such proposal.
The cost of this solicitation of proxies will be paid by us. It
is anticipated that the proxies will be solicited only by mail,
except that solicitation personally or by telephone may also be
made by our regular employees who will receive no additional
compensation for their services in connection with the
solicitation. Arrangements will be made with brokerage houses
and other custodians, nominees and fiduciaries for the
forwarding of solicitation materials and the annual report to
beneficial owners of stock held by such persons. We will
reimburse such parties for their expenses in so doing.
A copy of our 2007 Annual Report of the Company accompanies this
Proxy Statement. A copy of our Annual Report on
Form 10-K
for fiscal year 2007 will be provided without charge on written
request of any stockholder whose proxy is being solicited by the
Board of Directors. The written request should be directed to
Corporate Secretary, Criticare Systems, Inc., 20925 Crossroads
Circle, Suite 100, Waukesha, Wisconsin 53186.
BY ORDER OF THE BOARD OF DIRECTORS
Joel D. Knudson, Secretary
Waukesha, Wisconsin
October 30, 2007
21
Mark Here CRITICARE SYSTEMS, INC. for Address Change or Comments PLEASE SEE REVERSE SIDE
PLEASE MARK VOTES AS IN THIS EXAMPLE USING DARK INK ONLY. X FOR WITHHELD FOR ALL FOR AGAINST
ABSTAIN 1 . ELECTION OF DIRECTORS: 2. To ratify the appointment of BDO Seidman, LLP as the (terms
expiring at the 2008 Annual Meeting) Companys independent registered public accounting firm for
the 2008 fiscal year. Nominees: 3. In their discretion, the Proxies are authorized to vote upon
such other matters as may properly 0 1 Jeffrey T. Barnes come before the meeting. 0 2 N.C. Joseph
Lai, Ph.D. 03 William M. Moore 04 Robert E. Munzenrid er 0 5 Emil H. Soik a (Instructions: To
withhold authority to vote for any indicated nominee, write the name(s) or numbers of such
nominee(s) below.) Signature Signature Date If signing as attorney, executor, administrator,
trustee or guardian, please add your full title as such. If shares are held by two or more persons,
all holders must sign the Proxy. FOLD AND DETACH HERE YOUR VOTE IS IMPORTANT! PLEASE VOTE, SIGN,
DATE AND MAIL THE PROXY CARD PROMPTLY USING THE ENCLOSED ENVELOPE. Choose MLinkSM for fast, easy
and secure 24/7 online access to your future proxy materials, investment plan statements, tax
documents and more. Simply log on to Investor ServiceDirect® at
www.lasalleshareholderservices.com/isd/ where step-by-step instructions will prompt you through
enrollment. |
PROXY CRITICARE SYSTEMS, INC. PROXY 2007 ANNUAL MEETING OF STOCKHOLDERS THIS PROXY IS SOLICITED ON
BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints Emil H. Soika and Joel D. Knudson,
or either one of them, each with full power of substitution and resubstitution, as proxy or proxies
of the undersigned to attend the Annual Meeting of Stockholders of Criticare Systems, Inc. to be
held on November 27, 2007 at 4:00 p.m., lo cal time, at 20925 Crossroads Circle , Suite 100,
Waukesha, Wisconsin 53186, and at any adjournment thereof, there to vote all shares of stock of
Criticare Systems, Inc. which the undersigned would be entitled to vote if personally present as
specified upon the following matters and in their discretion upon such other matters as may
properly come before the meeting. The undersigned hereby acknowledges receipt of the Notice of
Annual Meeting of Stockholders and accompanying Proxy Statement, ratifies al that said proxies or
their substitutes may la wfully do by virtue hereof, and revokes al former proxies. Please sign
exactly as your name appears hereon, date and return this Proxy. UNLESS OTHERWISE SPECIFIED, THIS
PROXY WILL BE VOTED TO GRANT AUTHORITY TO ELECT THE NOMINATED DIRECTORS AND TO RATIFY THE
APPOINTMENT OF BDO SEIDMAN, LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR
THE 2008 FISCAL YEAR. IF OTHER MATTERS COME BEFORE THE MEETING, THIS PROXY WILL BE VOTED IN
ACCORDANCE WITH THE BEST JUDGMENT OF THE PROXIES APPOINTED. DETACH BELOW AND RETURN USING THE
ENVELOPE PROVIDED Address Change/Comments (Mark the corresponding box on the reverse side) FOLD AND
DETACH HERE |